Middle East & Africa Human Growth Hormone Market Size & Outlook
The human growth hormone market in Middle East & Africa is expected to reach a projected revenue of US$ 701.1 million by 2030. A compound annual growth rate of 12.5% is expected of Middle East & Africa human growth hormone market from 2024 to 2030.
Revenue, 2023 (US$M)
$308.3
Forecast, 2030 (US$M)
$701.1
CAGR, 2024 - 2030
12.5%
Report Coverage
Middle East & Africa
Middle East Africa Human Growth Hormone Market, 2018-2030 (US$M)
Global Market
Related Markets
MEA human growth hormone market highlights
- The MEA human growth hormone market generated a revenue of USD 308.3 million in 2023.
- The market is expected to grow at a CAGR of 12.5% from 2024 to 2030.
- In terms of segment, growth hormone deficiency was the largest revenue generating application in 2023.
- Small for Gestational Age is the most lucrative application segment registering the fastest growth during the forecast period.
- Country-wise, South Africa is expected to register the highest CAGR from 2024 to 2030.
MEA data book summary
| Market revenue in 2023 | USD 308.3 million |
| Market revenue in 2030 | USD 701.1 million |
| Growth rate | 12.5% (CAGR from 2023 to 2030) |
| Largest segment | Growth hormone deficiency |
| Fastest growing segment | Small for Gestational Age |
| Historical data covered | 2018 - 2022 |
| Base year for estimation | 2023 |
| Forecast period covered | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Turner Syndrome, Idiopathic Short Stature, Prader-Willi Syndrome, Small for Gestational Age, Other Applications, Growth Hormone Deficiency |
| Key market players worldwide | Novo Nordisk A/S ADR, Eli Lilly and Co, Pfizer Inc, Sandoz Group AG ADR, Roche, Ferring, Ipsen SA, Teva Pharmaceutical Industries Ltd |
Other key industry trends
- In terms of revenue, MEA region accounted for 4.9% of the global human growth hormone market in 2023.
- Globally, North America is projected to lead the regional market in terms of revenue in 2030.
- Asia Pacific is the fastest growing regional market and is projected to reach USD 2,726.0 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Three ways to get this data
Subscribe to the databook, customize it, or ask a question.Horizon Databook
Unlock every chart on this page and get dashboard access
- Statistics1.2M+ across all markets
- Databooks30K+ global, 120K+ country
- Companies200K+ profiles
- ExportPDF, Dashboard, XLS & PNG, licensed to cite
Customize it
Customize data as per your requirement
- AddCountries, segments, years
- RecutTo your product definition
- ExtendCompany-level detail
- OrA bespoke databook
- Turnaround5–10 working days
Ask Prism AI
A cited answer in seconds
- Corpus30,000 studies, 1.2M points
- ScopeAll markets, not just this
- CitationTraced to report & table
- HonestySays "not covered" if so
- SpeedSeconds, not days
Human Growth Hormone Market Scope
Human Growth Hormone Market segmentation & scope
Human Growth Hormone Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|---|---|---|---|
| Teva Pharmaceutical Industries Ltd | View profile | 37,851 | 124 Dvora HaNevi’a Street, Tel Aviv, Israel, 6944020 | www.tevapharm.com |
| Pfizer Inc | View profile | 88,000 | 66 Hudson Boulevard East, New York, NY, United States, 10001-2192 | www.pfizer.com |
| Eli Lilly and Co | View profile | 43,000 | Lilly Corporate Center, Indianapolis, IN, United States, 46285 | www.lilly.com |
| Novo Nordisk A/S ADR | View profile | 66,015 | Novo Alle 1, Bagsvaerd, Denmark, 2880 | www.novonordisk.com |
| Roche | View profile | 10001+ | Basel, Basel-Stadt, Switzerland, Europe | www.roche.com |
| Ferring | View profile | 5001-10000 | Saint-prex, Vaud, Switzerland, Europe | www.ferring.com |
| Ipsen SA | View profile | 5,325 | 65 Quai Georges Gorse, Billancourt Cedex, Boulogne, France, 92100 | www.ipsen.com |
| Sandoz Group AG ADR | View profile | - | - | - |
Middle East & Africa Human Growth Hormone Market Outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to Human Growth Hormone Market Outlook will help companies and investors design strategic landscapes.
Growth Hormone Deficiency was the largest segment with a revenue share of 50.76% in 2023.
Horizon Databook has segmented the Middle East & Africa human growth hormone market based on turner syndrome, idiopathic short stature, prader-willi syndrome, small for gestational age, other applications, growth hormone deficiency covering the revenue growth of each sub-segment from 2018 to 2030.
- Middle East & Africa Human Growth Hormone Market Application Outlook (Revenue, USD Million , 2018-2030)
- Turner Syndrome
- Idiopathic Short Stature
- Prader-Willi Syndrome
- Small for Gestational Age
- Other Applications
- Growth Hormone Deficiency
- Middle East & Africa Human Growth Hormone Market Distribution Channel Outlook (Revenue, USD Million , 2018-2030)
- Hospital Pharmacy
- Retail Pharmacy
- Online Pharmacy
- Specialty Pharmacy
- Middle East & Africa Human Growth Hormone Market Product Outlook (Revenue, USD Million , 2018-2030)
- Long Acting
- Other Products
Reasons to subscribe to Human Growth Hormone Market Outlook databook
- Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
- Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
- Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
- Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
- Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Human Growth Hormone Market Outlook databook
- Our clientele includes a mix of Human Growth Hormone Market Outlook companies, investment firms, advisory firms & academic institutions.
- 30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
- Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
- The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of continent-level data and insights on the Middle East & Africa Human Growth Hormone Market Outlook, including forecasts for subscribers. This continent databook contains high-level insights into Middle East & Africa Human Growth Hormone Market Outlook from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Middle East Africa Human Growth Hormone Market, 2018-2030 (US$M)
MEA human growth hormone market statistics, by application, 2018-2030 (US$M)
